Header Logo

Connection

SETH LERNER to Everolimus

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Everolimus.
SETH LERNER
Connection Strength
0.461
Everolimus
  1. Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 08 01; 7(8):e2425288.
    View in: PubMed
    Score: 0.232
  2. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. Eur Urol. 2024 Sep; 86(3):258-264.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.